X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6986) 6986
Book Review (624) 624
Publication (263) 263
Newsletter (131) 131
Magazine Article (85) 85
Conference Proceeding (25) 25
Book Chapter (8) 8
Book / eBook (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5464) 5464
humans (5059) 5059
male (3219) 3219
female (2620) 2620
prednisone (2061) 2061
adult (2035) 2035
prednisone - therapeutic use (1971) 1971
middle aged (1851) 1851
prednisone - pharmacology (1726) 1726
prednisone - administration & dosage (1429) 1429
aged (1177) 1177
oncology (1110) 1110
animals (1044) 1044
pharmacology & pharmacy (981) 981
antineoplastic combined chemotherapy protocols - therapeutic use (958) 958
adolescent (826) 826
immunology (790) 790
transplantation (763) 763
treatment outcome (692) 692
surgery (670) 670
drug therapy, combination (669) 669
abridged index medicus (667) 667
corticosteroids (644) 644
vincristine - administration & dosage (637) 637
child (612) 612
time factors (610) 610
chemotherapy (576) 576
cyclophosphamide - administration & dosage (558) 558
azathioprine - therapeutic use (540) 540
immunosuppressive agents - therapeutic use (538) 538
therapy (521) 521
doxorubicin - administration & dosage (487) 487
follow-up studies (447) 447
prednisone - adverse effects (435) 435
kidney transplantation (427) 427
prostate cancer (412) 412
old medline (408) 408
retrospective studies (399) 399
risk factors (398) 398
cancer (387) 387
cyclosporine - therapeutic use (368) 368
drug therapy (368) 368
medicine & public health (365) 365
kidney transplantation - immunology (361) 361
child, preschool (355) 355
rats (355) 355
antineoplastic combined chemotherapy protocols - adverse effects (349) 349
aged, 80 and over (348) 348
prognosis (342) 342
dose-response relationship, drug (341) 341
drug administration schedule (341) 341
docetaxel (338) 338
research (336) 336
care and treatment (330) 330
prednisone, adverse reactions - serious (323) 323
pharmacology/toxicology (310) 310
antineoplastic combined chemotherapy protocols - administration & dosage (308) 308
glucocorticoids - pharmacology (306) 306
prostatic neoplasms - drug therapy (297) 297
clinical trials as topic (295) 295
transplantation, homologous (290) 290
cyclophosphamide - therapeutic use (285) 285
complications and side effects (272) 272
immunosuppression (266) 266
mitoxantrone (264) 264
steroids (264) 264
survival (262) 262
antineoplastic agents - therapeutic use (259) 259
administration, oral (257) 257
vincristine - therapeutic use (255) 255
mice (254) 254
prospective studies (253) 253
pharmacology (252) 252
combined modality therapy (244) 244
dosage and administration (244) 244
glucocorticoids - therapeutic use (244) 244
cyclophosphamide (243) 243
rituximab (241) 241
survival rate (241) 241
hematology (236) 236
disease-free survival (233) 233
analysis (229) 229
survival analysis (227) 227
trial (224) 224
glucocorticoids (214) 214
children (212) 212
health aspects (209) 209
anti-inflammatory agents - therapeutic use (208) 208
dexamethasone (208) 208
expression (207) 207
disease (206) 206
prednisolone (206) 206
antineoplastic agents - pharmacology (203) 203
immunosuppressive agents - pharmacology (201) 201
case studies (196) 196
cyclosporins - therapeutic use (195) 195
kidney transplantation - physiology (195) 195
lymphoma, non-hodgkin - drug therapy (195) 195
neoplasm staging (193) 193
diagnosis (190) 190
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6577) 6577
Italian (175) 175
German (158) 158
French (90) 90
Polish (65) 65
Spanish (47) 47
Chinese (36) 36
Russian (17) 17
Japanese (13) 13
Czech (6) 6
Danish (5) 5
Dutch (5) 5
Portuguese (5) 5
Hungarian (3) 3
Romanian (3) 3
Serbian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2016, Volume 383, Issue 2, pp. 309 - 317
Abstract In previous studies we demonstrated that targeting the nuclear exporter protein exportin-1 (CRM1/XPO1) by a selective inhibitor of nuclear export... 
Hematology, Oncology and Palliative Medicine | NHL | XPO1 | Selective inhibitors of nuclear export | SINE | CRM1 | Exportin-1 | SURVIVAL | DRUG-RESISTANCE | MODEL | CANCER | STRATEGIES | ONCOLOGY | LINE | CHOP | PROTEINS | Vincristine - pharmacology | TOR Serine-Threonine Kinases - metabolism | Transcription Factor RelA - antagonists & inhibitors | Apoptosis - drug effects | Humans | Lymphoma, Non-Hodgkin - enzymology | Lymphoma, Non-Hodgkin - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Dexamethasone - pharmacology | Time Factors | Oxadiazoles - pharmacology | Acrylamides - pharmacology | Lymphoma, Non-Hodgkin - drug therapy | Cell Survival - drug effects | Hydrazines - pharmacology | Everolimus - pharmacology | Mice, SCID | Mice, Inbred ICR | Drug Synergism | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Karyopherins - metabolism | Signal Transduction - drug effects | Transcription Factor RelA - metabolism | Tumor Burden - drug effects | Active Transport, Cell Nucleus - drug effects | Cyclophosphamide - pharmacology | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Cell Line, Tumor | Prednisone - pharmacology | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Karyopherins - antagonists & inhibitors | Doxorubicin - pharmacology | Receptors, Cytoplasmic and Nuclear - metabolism | International trade | Cyclophosphamide | Care and treatment | Dexamethasone | Analysis | Lymphomas | Prednisone | Exports | Steroids | Cancer | Drugs | TOR protein | Animal models | Laboratories | Toxicity | Xenotransplantation | Clinical trials | Cytotoxicity | Kinases | Experiments | Anticancer properties | Proteins | Cell growth | Antitumor agents | Cell cycle | Xenografts | Biocompatibility | Localization | Drug dosages | NF-κB protein | Chronic lymphatic leukemia | Hematology | Pharmacology | Chemical compounds | Patients | Lymphoma | Nuclear transport | Studies | Inhibitors | Response rates | In vivo methods and tests | Apoptosis | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, pp. e111840 - e111840
Patients with non-Hodgkin lymphoma (NHL) are treated today with a cocktail of drugs referred to as CHOP (Cyclophosphamide, Hydroxyldaunorubicin, Oncovin, and... 
PROTEIN METHYLTRANSFERASES | SELECTIVE-INHIBITION | MOLECULAR SUBTYPES | APOPTOSIS | B-CELL LYMPHOMA | MULTIDISCIPLINARY SCIENCES | DRUG DISCOVERY | RESISTANCE | MECHANISMS | CANCER | SOMATIC MUTATIONS | Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors | Neoplasm Transplantation | Vincristine - pharmacology | Humans | Receptors, Glucocorticoid - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Receptors, Glucocorticoid - agonists | Dexamethasone - pharmacology | Female | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical | Lymphoma, Non-Hodgkin - drug therapy | Enhancer of Zeste Homolog 2 Protein - metabolism | Random Allocation | Mice, SCID | Prednisolone - pharmacology | Animals | Cyclophosphamide - pharmacology | Lymphoma, Non-Hodgkin - metabolism | Cell Line, Tumor | Glucocorticoids - pharmacology | Prednisone - pharmacology | Doxorubicin - pharmacology | Pyridones - pharmacology | Care and treatment | Corticosteroids | Fluocinolone acetonide | Central nervous system depressants | Analysis | Histones | Models | Non-Hodgkin's lymphomas | Immunosuppressive agents | Steroids | Cancer | Signal transduction | Enzymes | Cell growth | Glucocorticoids | Research & development--R&D | Lymphomas | Mutation | Gene expression | Apoptosis | Index Medicus | Research & development | R&D
Journal Article
Blood, ISSN 0006-4971, 09/2007, Volume 110, Issue 6, pp. 2084 - 2091
Incorporation of apoptosis-inducing agents into current therapeutic regimens is an attractive strategy to improve treatment for drug-resistant leukemia. We... 
X-LINKED INHIBITOR | INDUCED APOPTOSIS | GENES | RECEPTOR | HEMATOLOGY | NF-KAPPA-B | EXPRESSION | CHILDHOOD | CANCER | BH3-ONLY PROTEINS | ACUTE PROMYELOCYTIC LEUKEMIA | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Drug Resistance, Neoplasm | Cell Line, Tumor - drug effects | Antineoplastic Agents - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Dexamethasone - pharmacology | Transfection | Neoplasm, Residual - diagnosis | bcl-Associated Death Protein - metabolism | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Proto-Oncogene Proteins c-akt - metabolism | Oxides - administration & dosage | Cell Survival - drug effects | Signal Transduction | Arsenicals - pharmacology | RNA, Small Interfering - pharmacology | Remission Induction | Sirolimus - pharmacology | Blotting, Western | Drug Synergism | Oxides - pharmacology | Arsenicals - administration & dosage | X-Linked Inhibitor of Apoptosis Protein - metabolism | Glucocorticoids - pharmacology | Prednisone - pharmacology | Caspases | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Cell Line; Tumor/drug effects | Prednisone/pharmacology | Cell Survival/drug effects | Proto-Oncogene Proteins c-akt/metabolism | MEDICINE | Drug Resistance; Neoplasm | Sirolimus/pharmacology | Arsenicals/administration & dosage/pharmacology | X-Linked Inhibitor of Apoptosis Protein/metabolism | Antineoplastic Agents/administration & dosage/pharmacology | Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/metabolism/pathology | Reactive Oxygen Species/metabolism | Blotting; Western | Neoplasm; Residual/diagnosis | RNA; Small Interfering/pharmacology | Apoptosis/drug effects | Glucocorticoids/pharmacology | bcl-Associated Death Protein/metabolism | MEDICIN | Dexamethasone/pharmacology | Oxides/administration & dosage/pharmacology | Phosphorylation/drug effects
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 2009, Volume 44, Issue 12, pp. 4787 - 4792
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0128696 - e0128696
Lung cancer causes over one million deaths every year worldwide. However, prevention and treatment methods for this serious disease are limited. The... 
MITOXANTRONE PLUS PREDNISONE | OXIDATIVE STRESS | MULTIDISCIPLINARY SCIENCES | DNA-DAMAGE | PHASE-III | PIK3CA MUTATION | TRANS-RETINOIC ACID | INDUCED MALIGNANT-TRANSFORMATION | RESISTANT PROSTATE-CANCER | INDUCED GROWTH-INHIBITION | SOMATIC MUTATIONS | Colchicine - pharmacology | Lung Neoplasms - drug therapy | Arsenicals - pharmacology | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Daunorubicin - pharmacology | Drug Discovery - methods | Carcinogenesis - metabolism | Small Cell Lung Carcinoma - drug therapy | Digoxin - pharmacology | Carcinogenesis - drug effects | Small Cell Lung Carcinoma - metabolism | Berberine - pharmacology | Animals | Lung - drug effects | Prednisone - pharmacology | Antineoplastic Agents - pharmacology | Lung - metabolism | Carcinoma, Non-Small-Cell Lung - drug therapy | Ouabain - pharmacology | Tretinoin - pharmacology | Health aspects | Lung cancer | Analysis | Health sciences | Oxidative stress | Arsenic | Identification methods | DNA damage | Lung | Kinases | Cancer therapies | Prevention | Proteins | Liver cancer | Life sciences | Tumorigenesis | Growth factors | Deoxyribonucleic acid--DNA | Medical treatment | Disease control | Chemicals | Computer science | Chemotherapy | Information processing | Mutation | Methods | Cancer | Apoptosis | Pharmaceuticals | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Cancer Research, ISSN 0008-5472, 11/2009, Volume 69, Issue 21, pp. 8386 - 8394
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 319 - 327
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 04/2014, Volume 387, Issue 1-2, pp. 8 - 18
Journal Article
Journal Article
Veterinary and Comparative Oncology, ISSN 1476-5810, 06/2019, Volume 17, Issue 2, pp. 165 - 173
Journal Article